Most Common Bacteria Causing Pyelonephritis
Escherichia coli (E. coli) is the most common bacteria causing pyelonephritis, accounting for more than 75% of all cases. 1
Epidemiology and Microbiology
Pyelonephritis is a serious upper urinary tract infection affecting the renal parenchyma, with approximately 250,000 cases occurring annually in the United States, resulting in costs as high as $2.1 billion 1. The microbial spectrum of pyelonephritis consists primarily of:
Clinical Relevance of Bacterial Etiology
Understanding that E. coli is the predominant pathogen has important implications for empiric antibiotic selection:
- In uncomplicated pyelonephritis, empiric therapy should target E. coli 1
- For patients requiring hospitalization, initial IV antimicrobial regimens should cover E. coli and other common uropathogens 1
Antibiotic Resistance Considerations
The increasing prevalence of antimicrobial resistance affects treatment decisions:
- Fluoroquinolone resistance in Enterobacteriaceae is increasing, necessitating reevaluation of empiric therapy choices 1
- TMP-SMX should not be used alone as empirical therapy without culture and susceptibility testing due to high resistance rates 1
- When local resistance to a chosen oral antibiotic likely exceeds 10%, one dose of a long-acting broad-spectrum parenteral antibiotic should be given while awaiting susceptibility data 5
Special Populations
- Complicated UTIs: Patients with structural abnormalities, immunosuppression, diabetes, or recent instrumentation may have infections caused by organisms other than E. coli 6
- Hospitalized patients: May have higher rates of resistant organisms and require broader empiric coverage 1
- Pregnant women: Require prompt treatment and are at higher risk for severe complications 7, 5
Diagnostic Approach
For suspected pyelonephritis:
- Urine culture with antimicrobial susceptibility testing should be performed in all patients to confirm the causative organism 8, 5
- Blood cultures should be reserved for patients with uncertain diagnosis, immunocompromised status, or suspected hematogenous infections 2
Treatment Implications
Since E. coli is the predominant pathogen, empiric therapy should be directed accordingly:
- For outpatient treatment: Fluoroquinolones or TMP-SMX (if local resistance is <10%) 1
- For inpatient treatment: IV fluoroquinolones, aminoglycosides with or without ampicillin, or extended-spectrum cephalosporins 1, 2
Understanding the bacterial etiology of pyelonephritis is essential for appropriate empiric antibiotic selection and for reducing morbidity and mortality associated with this serious infection.